Cargando…
Translatability scoring in prospective and retrospective COVID drug development cases
BACKGROUND: The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 has led to an enormous surge of clinical research. So far, the speed and success rate of related drug development projects, especially of vaccines, is unprecedented. For the first time, this situation allowed for the...
Autores principales: | Wendler, Alexandra, Wehling, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243273/ https://www.ncbi.nlm.nih.gov/pubmed/37278822 http://dx.doi.org/10.1007/s00228-023-03517-0 |
Ejemplares similares
-
Translatability scoring in drug development: eight case studies
por: Wendler, Alexandra, et al.
Publicado: (2012) -
Translatability score revisited: differentiation for distinct disease areas
por: Wendler, Alexandra, et al.
Publicado: (2017) -
Translational medicine: science or wishful thinking?
por: Wehling, Martin
Publicado: (2008) -
Calling for an exponential escalation scheme in vaccine development for COVID-19
por: Wehling, Martin
Publicado: (2020) -
Correction to: Calling for an exponential escalation scheme in vaccine development for COVID-19
por: Wehling, Martin
Publicado: (2021)